Found: 417
Select item for more details and to access through your institution.
Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72139-y
- By:
- Publication type:
- Article
The validity of pathology codes for biopsy-confirmed kidney disease in the Danish National Patobank.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 8, p. 1, doi. 10.1093/ckj/sfae203
- By:
- Publication type:
- Article
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
- Published in:
- Diabetologia, 2024, v. 67, n. 1, p. 3, doi. 10.1007/s00125-023-06015-1
- By:
- Publication type:
- Article
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2022, v. 65, n. 12, p. 1925, doi. 10.1007/s00125-022-05787-2
- By:
- Publication type:
- Article
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
- Published in:
- Diabetologia, 2022, v. 65, n. 7, p. 1085, doi. 10.1007/s00125-022-05694-6
- By:
- Publication type:
- Article
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
- Published in:
- Diabetologia, 2020, v. 63, n. 12, p. 2713, doi. 10.1007/s00125-020-05260-y
- By:
- Publication type:
- Article
Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD).
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2020, v. 63, n. 2, p. 221, doi. 10.1007/s00125-019-05039-w
- By:
- Publication type:
- Article
Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study.
- Published in:
- Diabetologia, 2019, v. 62, n. 12, p. 2354, doi. 10.1007/s00125-019-05009-2
- By:
- Publication type:
- Article
Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study.
- Published in:
- Diabetologia, 2019, v. 62, n. 9, p. 1575, doi. 10.1007/s00125-019-4920-3
- By:
- Publication type:
- Article
Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2018, v. 61, n. 12, p. 2461, doi. 10.1007/s00125-018-4729-5
- By:
- Publication type:
- Article
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study.
- Published in:
- Diabetologia, 2018, v. 61, n. 8, p. 1724, doi. 10.1007/s00125-018-4642-y
- By:
- Publication type:
- Article
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
- Published in:
- Diabetologia, 2018, v. 61, n. 1, p. 231, doi. 10.1007/s00125-017-4470-5
- By:
- Publication type:
- Article
Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
- Published in:
- Diabetologia, 2017, v. 60, n. 10, p. 1883, doi. 10.1007/s00125-017-4344-x
- By:
- Publication type:
- Article
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
- Published in:
- Diabetologia, 2016, v. 59, n. 11, p. 2298, doi. 10.1007/s00125-016-4065-6
- By:
- Publication type:
- Article
Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
- Published in:
- Diabetologia, 2016, v. 59, n. 7, p. 1549, doi. 10.1007/s00125-016-3937-0
- By:
- Publication type:
- Article
Cardiac Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 2, p. 371, doi. 10.1007/s00125-015-3799-x
- By:
- Publication type:
- Article
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 1, p. 81, doi. 10.1007/s00592-020-01581-x
- By:
- Publication type:
- Article
A marker of type VI collagen formation (PRO-C6) is associated with higher arterial stiffness in type 1 diabetes.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 6, p. 711, doi. 10.1007/s00592-019-01306-9
- By:
- Publication type:
- Article
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 11, p. 1143, doi. 10.1007/s00592-018-1205-0
- By:
- Publication type:
- Article
Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients—the Thousand & 1 Study.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 1, p. 21, doi. 10.1007/s00592-017-1062-2
- By:
- Publication type:
- Article
Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness.
- Published in:
- Acta Diabetologica, 2014, v. 51, n. 6, p. 955, doi. 10.1007/s00592-014-0619-6
- By:
- Publication type:
- Article
Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.
- Published in:
- Acta Diabetologica, 2014, v. 51, n. 6, p. 973, doi. 10.1007/s00592-014-0651-6
- By:
- Publication type:
- Article
Renoprotection by blocking the RAAS in diabetic nephropathy—fact or fiction?
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 9, p. 2354, doi. 10.1093/ndt/gfl454
- By:
- Publication type:
- Article
Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 7, p. 2030, doi. 10.1093/ndt/gfl012
- By:
- Publication type:
- Article
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2003, v. 18, n. 2, p. 293, doi. 10.1093/ndt/18.2.293
- By:
- Publication type:
- Article
Optimal dose of losartan for renoprotection in diabetic nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2002, v. 17, n. 8, p. 1413, doi. 10.1093/ndt/17.8.1413
- By:
- Publication type:
- Article
Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy.
- Published in:
- Nephrology Dialysis Transplantation, 1996, v. 11, n. 6, p. 1019, doi. 10.1093/ndt/11.6.1019
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 2, p. 1, doi. 10.1093/gerona/glad181
- By:
- Publication type:
- Article
Copenhagen Diabetes Consensus (CODIAC) 2021: User involvement in diabetes care, prevention and research.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 1, p. 1, doi. 10.1111/dme.15160
- By:
- Publication type:
- Article
In vivo molecular imaging of cardiac angiogenesis in persons with and without type 2 diabetes: A cross‐sectional <sup>68</sup> Ga‐RGD‐PET study.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 1, p. 1, doi. 10.1111/dme.14960
- By:
- Publication type:
- Article
Urinary peptidome and diabetic retinopathy in the DIRECT‐Protect 1 and 2 trials.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14634
- By:
- Publication type:
- Article
Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 6, p. 1, doi. 10.1111/dme.14517
- By:
- Publication type:
- Article
Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 5, p. 1, doi. 10.1111/dme.14459
- By:
- Publication type:
- Article
Performance of new and panel CKD‐EPI equations in European adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2501, doi. 10.1111/dom.15536
- By:
- Publication type:
- Article
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2128, doi. 10.1111/dom.15518
- By:
- Publication type:
- Article
Association of carpal tunnel syndrome with incident diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1976, doi. 10.1111/dom.15482
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Albuminuria‐lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo‐controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 54, doi. 10.1111/dom.15287
- By:
- Publication type:
- Article
Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3152, doi. 10.1111/dom.15209
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 3064, doi. 10.1111/dom.15180
- By:
- Publication type:
- Article
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2888, doi. 10.1111/dom.15183
- By:
- Publication type:
- Article
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2605, doi. 10.1111/dom.15146
- By:
- Publication type:
- Article
Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2413, doi. 10.1111/dom.15109
- By:
- Publication type:
- Article
Sotagliflozin, a dual sodium‐glucose co‐transporter‐1 and sodium‐glucose co‐transporter‐2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1874, doi. 10.1111/dom.15047
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article